Skip to main content
Clinical Trials/JPRN-UMIN000052109
JPRN-UMIN000052109
Not yet recruiting
未知

The effect of adjuvant chemotherapy on the prognosis in the patients with familial pancreatic cancer (JON2201-P) - The effect of adjuvant chemotherapy on the prognosis in the patients with familial pancreatic cancer (JON2201-P)

Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)0 sites500 target enrollmentSeptember 6, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Pancreatic cancer treated with postoperative adjuvant chemotherapy
Sponsor
Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)
Enrollment
500
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 6, 2023
End Date
March 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with preoperative chemotherapy (neoadjuvant chemotherapy or neoadjuvant chemo\-radiotherapy) 2\. Patients who have not undergone R0 or R1 resection 3\. Histological types other than pancreatic ductal cancer 4\. Patients who have not been treated by postoperative adjuvant chemotherapy 5\. Patients who have opted out and have been refused access to medical information by research subjects or their familiy

Outcomes

Primary Outcomes

Not specified

Similar Trials